News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
563,455 Results
Type
Article (47382)
Company Profile (109)
Press Release (515956)
Multimedia
Podcasts (173)
Webinars (23)
Section
Business (146078)
Career Advice (2432)
Deals (28243)
Drug Delivery (168)
Drug Development (68807)
Employer Resources (160)
FDA (16150)
Job Trends (12116)
News (266353)
Policy (29949)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2355)
Academic (1)
Accelerated approval (57)
ADA (43)
Adcomms (42)
Allergies (183)
Alliances (36164)
ALS (217)
Alzheimer's disease (1869)
Antibody-drug conjugate (ADC) (500)
Approvals (16465)
Artificial intelligence (692)
ASCO (304)
Autoimmune disease (339)
Automation (53)
Bankruptcy (315)
Best Places to Work (9199)
BIO (63)
BIOSECURE Act (23)
Biosimilars (235)
Biotechnology (63)
Bladder cancer (204)
Brain cancer (72)
Breast cancer (739)
Cancer (5944)
Cardiovascular disease (513)
Career advice (2073)
Career pathing (49)
CAR-T (319)
CDC (77)
Celiac Disease (2)
Cell therapy (920)
Cervical cancer (51)
Clinical research (60765)
Collaboration (1909)
Commercialization (1)
Company closure (7)
Compensation (1493)
Complete response letters (108)
COVID-19 (2762)
CRISPR (114)
C-suite (1139)
Cystic fibrosis (154)
Data (8089)
Decentralized trials (3)
Denatured (39)
Depression (191)
Dermatology (94)
Diabetes (625)
Diagnostics (5824)
Digital health (49)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (320)
Drug pricing (242)
Drug shortages (34)
Duchenne muscular dystrophy (316)
Earnings (64313)
Editorial (80)
Employer branding (20)
Employer resources (144)
Events (84993)
Executive appointments (1032)
FDA (20123)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (32)
Funding (1617)
Gene editing (242)
Generative AI (62)
Gene therapy (757)
GLP-1 (1194)
Government (4297)
Grass and pollen (8)
Guidances (408)
Healthcare (15137)
Hematology (173)
HIV (91)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (114)
Immunology and inflammation (347)
Immuno-oncology (101)
Indications (207)
Infectious disease (3116)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (131)
Intellectual property (302)
Interviews (459)
IPO (14172)
IRA (58)
Job creations (3181)
Job search strategy (1677)
JPM (69)
Kidney cancer (22)
Labor market (112)
Layoffs (650)
Leadership (52)
Legal (7025)
Liver cancer (102)
Longevity (27)
Lung cancer (776)
Lymphoma (449)
Machine learning (61)
Management (53)
Manufacturing (1056)
Marketing (4)
MASH (216)
Medical affairs (1)
Medical device (11780)
Medtech (11925)
Mergers & acquisitions (15270)
Metabolic disorders (1687)
mRNA (250)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (466)
Neuropsychiatric disorders (125)
Neuroscience (3470)
Neurotech (2)
NextGen: Class of 2026 (5004)
Non-profit (3211)
Now hiring (37)
Obesity (830)
Opinion (317)
Ovarian cancer (221)
Pain (245)
Pancreatic cancer (343)
Parkinson's disease (387)
Partnered (29)
Patents (616)
Patient recruitment (725)
Peanut (64)
People (45148)
Pharmaceutical (34)
Pharmacy benefit managers (36)
Phase 1 (18247)
Phase 2 (26331)
Phase 3 (21501)
Pipeline (9305)
Policy (393)
Postmarket research (2213)
Preclinical (7408)
Press Release (28)
Prostate cancer (335)
Psychedelics (69)
Radiopharmaceuticals (306)
Rare diseases (1230)
Real estate (4315)
Recruiting (66)
Regulatory (24537)
Reports (47)
Research institute (2150)
Resumes & cover letters (406)
Rett syndrome (46)
RNA editing (25)
RSV (85)
Schizophrenia (188)
Series A (283)
Series B (216)
Service/supplier (7)
Sickle cell disease (119)
Special edition (30)
Spinal muscular atrophy (151)
Sponsored (52)
Startups (2824)
State (1)
Stomach cancer (21)
Supply chain (134)
Tariffs (104)
The Weekly (132)
Vaccines (1228)
Venture capital (135)
Weight loss (580)
Women's health (118)
Worklife (25)
Date
Today (106)
Last 7 days (461)
Last 30 days (2244)
Last 365 days (28523)
2026 (15173)
2025 (28388)
2024 (31385)
2023 (34986)
2022 (45065)
2021 (48497)
2020 (45512)
2019 (36216)
2018 (27399)
2017 (27805)
2016 (25807)
2015 (27978)
2014 (21779)
2013 (17796)
2012 (18970)
2011 (19387)
2010 (17516)
Location
Africa (692)
Alabama (73)
Alaska (6)
Arizona (287)
Arkansas (12)
Asia (32952)
Australia (5792)
California (12993)
Canada (3027)
China (1217)
Colorado (510)
Connecticut (581)
Delaware (394)
Europe (80948)
Florida (1986)
Georgia (397)
Hawaii (4)
Idaho (41)
Illinois (1000)
India (82)
Indiana (520)
Iowa (24)
Japan (570)
Kansas (113)
Kentucky (37)
Louisiana (39)
Maine (77)
Maryland (1557)
Massachusetts (9382)
Michigan (305)
Minnesota (679)
Mississippi (5)
Missouri (137)
Montana (13)
Nebraska (24)
Nevada (136)
New Hampshire (64)
New Jersey (3450)
New Mexico (17)
New York (3362)
North Carolina (1634)
North Dakota (8)
Northern California (6667)
Ohio (361)
Oklahoma (18)
Oregon (34)
Pennsylvania (2447)
Puerto Rico (25)
Rhode Island (34)
South America (1055)
South Carolina (84)
South Dakota (2)
Southern California (5124)
Tennessee (199)
Texas (2008)
United States (45177)
Utah (321)
Vermont (1)
Virginia (319)
Washington D.C. (74)
Washington State (1008)
West Virginia (4)
Wisconsin (132)
Wyoming (1)
563,455 Results for "grupo ferrer internacional s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prilenia and Ferrer Announce First Participant Enrolled in the “PREVAiLS” Phase 3 Study of Pridopidine in ALS
March 30, 2026
·
9 min read
Press Releases
Prilenia and Ferrer to Share New Data and Analyses of Pridopidine’s Impact on Huntington’s Disease at the Huntington Study Group (HSG) Congress
October 10, 2025
·
9 min read
Press Releases
Prilenia and Ferrer Announce FDA Clearance to Start the “PREVAiLS” Pivotal Phase 3 Study with Pridopidine in ALS
December 12, 2025
·
9 min read
Press Releases
Prilenia and Ferrer Provide Update on European Regulatory Process for Pridopidine in Huntington’s Disease
July 25, 2025
·
5 min read
Press Releases
Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule
October 21, 2025
·
7 min read
Press Releases
Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)
June 17, 2025
·
3 min read
Press Releases
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine
April 28, 2025
·
3 min read
Press Releases
Scipher Medicine expands its global presence, bringing precision medicine to Latin America through an alliance with Grupo Amarey
June 16, 2025
·
3 min read
Business
Verge Genomics and Ferrer Announce Agreement to Co-Develop Clinical-Stage ALS Therapy VRG50635
Verge Genomics and Ferrer have announced a strategic collaboration to co-develop VRG50635, Verge’s lead drug candidate, for the treatment of sporadic and familial forms of amyotrophic lateral sclerosis, in Europe, Central and South America, Southeast Asia, and Japan.
March 25, 2024
·
4 min read
Press Releases
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets
April 28, 2025
·
8 min read
1 of 56,346
Next
